HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hein, W. R. Articles by Avila, D. Search for Related Content PubMed PubMed Citation Articles by Hein, W. R. Articles by Avila, D.

Ubiquitination and Dimerization of Complement Receptor Type 2 on Sheep B Cells^{1 ,2}

Basel Institute for Immunology, Basel, Switzerland

Complement receptor type 2 (CR2) is a membrane-anchored glycoprotein that specifically binds C3d, as well as other ligands, and plays diverse roles in regulating immunity. Here we show that two distinct isoforms of CR2 are expressed on the surface of sheep B lymphocytes. One (CR2^no 150 kDa) is structurally similar to known mammalian homologues while the other (CR2^ub 190 kDa) has been modified by the covalent attachment of ubiquitin to the cytoplasmic domain and is identified for the first time. CR2^no and CR2^ub are expressed on the surface of sheep B cells as noncovalently associated dimers and the external topography of the two isoforms differs in some respect. The basis for these unusual higher-order structural properties may lie in the primary sequence of sheep CR2, since the transmembrane domain contains a region resembling a rare 7-amino acid dimerization motif, and two lysine residues in the cytoplasmic domain provide potential sites for posttranslational ubiquitination. The primary structures of sheep ubiquitin and C3d ligand are extensively conserved. In conjunction with the results of separate in vivo studies, these findings suggest that selective ubiquitination plays a role in modulating the higher-order structure and/or expression of CR2 during B cell development.

This article has been cited by other articles:

				D. Liu, J.-Y. Zhu, and Z.-X. Niu Molecular Structure and Expression of Anthropic, Ovine, and Murine Forms of Complement Receptor Type 2 Clin. Vaccine Immunol., June 1, 2008; 15(6): 901 - 910. [Full Text] [PDF]

				R. Heggebo, C. McL. Press, G. Gunnes, L. Gonzalez, and M. Jeffrey Distribution and accumulation of PrP in gut-associated and peripheral lymphoid tissue of scrapie-affected Suffolk sheep J. Gen. Virol., February 1, 2002; 83(2): 479 - 489. [Abstract] [Full Text] [PDF]

				M. Aleksandersen, K.-I. Lie, B. Gjerde, and T. Landsverk Lymphocyte Depletion in Ileal Peyer's Patch Follicles in Lambs Infected with Eimeria ovinoidalis Clin. Vaccine Immunol., January 1, 2002; 9(1): 83 - 91. [Abstract] [Full Text] [PDF]

				A. J. Young, W. L. Marston, and L. Dudler Subset-Specific Regulation of the Lymphatic Exit of Recirculating Lymphocytes In Vivo J. Immunol., September 15, 2000; 165(6): 3168 - 3174. [Abstract] [Full Text] [PDF]

				G. Strous and R Govers The ubiquitin-proteasome system and endocytosis J. Cell Sci., January 5, 1999; 112(10): 1417 - 1423. [Abstract] [PDF]